Browsing Tag
Paul Weiss Rifkind Wharton & Garrison LLP
2 posts
Lilly (NYSE: LLY) to acquire Orna Therapeutics for $2.4bn to expand in vivo CAR-T strategy
Eli Lilly and Company (LLY) to acquire Orna Therapeutics for up to $2.4B. Explore how in vivo CAR-T and circular RNA may transform autoimmune therapy.
February 12, 2026
$6.3bn gaming mega deal: Apollo Global Management to acquire International Game Technology and Everi Holdings
International Game Technology PLC (NYSE: IGT) and Everi Holdings Inc. (NYSE: EVRI) have announced a monumental deal that…
July 28, 2024